메뉴 건너뛰기




Volumn 44, Issue 5, 2013, Pages 281-285

3-phosphoglycerate dehydrogenase deficiency: Description of two new cases in Tunisia and review of the literature

Author keywords

epilepsy; microcephaly; serine; supplementation

Indexed keywords

CLONAZEPAM; GLYCINE; PHOSPHOGLYCERATE DEHYDROGENASE; PYRUVIC ACID; SERINE; VALPROIC ACID; VERY LONG CHAIN FATTY ACID; VIGABATRIN;

EID: 84885083172     PISSN: 0174304X     EISSN: 14391899     Source Type: Journal    
DOI: 10.1055/s-0033-1338133     Document Type: Article
Times cited : (7)

References (15)
  • 1
    • 1842557952 scopus 로고    scopus 로고
    • Serine-deficiency syndromes
    • DOI 10.1097/00019052-200404000-00019
    • de Koning T. J., Klomp L. W. Serine-deficiency syndromes. Curr Opin Neurol: 2004; 17 2 197 204 (Pubitemid 38446464)
    • (2004) Current Opinion in Neurology , vol.17 , Issue.2 , pp. 197-204
    • De Koning, T.J.1    Klomp, L.W.J.2
  • 4
    • 0033834892 scopus 로고    scopus 로고
    • 3-phosphoglycerate dehydrogenase deficiency in a patient with West syndrome
    • Pineda M., Vilaseca M. A., Artuch R., et al. 3-phosphoglycerate dehydrogenase deficiency in a patient with West syndrome. Dev Med Child Neurol: 2000; 42 9 629 633
    • (2000) Dev Med Child Neurol , vol.42 , Issue.9 , pp. 629-633
    • Pineda, M.1    Vilaseca, M.A.2    Artuch, R.3
  • 5
    • 0033652293 scopus 로고    scopus 로고
    • Molecular characterization of 3-phosphoglycerate dehydrogenase deficiency-A neurometabolic disorder associated with reduced L-serine biosynthesis
    • Klomp L. WJ, de Koning T. J., Malingré H. EM., et al. Molecular characterization of 3-phosphoglycerate dehydrogenase deficiency-a neurometabolic disorder associated with reduced L-serine biosynthesis. Am J Hum Genet: 2000; 67 6 1389 1399
    • (2000) Am J Hum Genet , vol.67 , Issue.6 , pp. 1389-1399
    • Klomp, L.W.1    De Koning, T.J.2    Malingré, H.E.3
  • 6
    • 0034826503 scopus 로고    scopus 로고
    • Phenotypic heterogeneity and adverse effects of serine treatment in 3-phosphoglycerate dehydrogenase deficiency: Report on two siblings
    • DOI 10.1055/s-2001-17373
    • Häusler M. G., Jaeken J., Mönch E., Ramaekers V. T. Phenotypic heterogeneity and adverse effects of serine treatment in 3-phosphoglycerate dehydrogenase deficiency: report on two siblings. Neuropediatrics: 2001; 32 4 191 195 (Pubitemid 32895901)
    • (2001) Neuropediatrics , vol.32 , Issue.4 , pp. 191-195
    • Hausler, M.G.1    Jaeken, J.2    Monch, E.3    Ramaekers, V.Th.4
  • 8
    • 33745105728 scopus 로고    scopus 로고
    • Treatment with amino acids in serine deficiency disorders
    • de Koning T. J. Treatment with amino acids in serine deficiency disorders. J Inherit Metab Dis: 2006; 29 2-3 347 351
    • (2006) J Inherit Metab Dis , vol.29 , Issue.23 , pp. 347-351
    • De Koning, T.J.1
  • 9
    • 76649102412 scopus 로고    scopus 로고
    • 3-phosphoglycerate dehydrogenase deficiency: A case report of a treatable cause of seizures
    • Coşkun T., Aydin H. I., Kiliç M., et al. 3-phosphoglycerate dehydrogenase deficiency: a case report of a treatable cause of seizures. Turk J Pediatr: 2009; 51 6 587 592
    • (2009) Turk J Pediatr , vol.51 , Issue.6 , pp. 587-592
    • Coşkun, T.1    Aydin, H.I.2    Kiliç, M.3
  • 11
    • 0034467971 scopus 로고    scopus 로고
    • Hypomyelination and reversible white matter attenuation in 3-phosphoglycerate dehydrogenase deficiency
    • DOI 10.1055/s-2000-12944
    • de Koning T. J., Jaeken J., Pineda M., Van Maldergem L., Poll-The B. T., van der Knaap M. S. Hypomyelination and reversible white matter attenuation in 3-phosphoglycerate dehydrogenase deficiency. Neuropediatrics: 2000; 31 6 287 292 (Pubitemid 32216607)
    • (2000) Neuropediatrics , vol.31 , Issue.6 , pp. 287-292
    • De Koning, T.J.1    Jaeken, J.2    Pineda, M.3    Van Maldergem, L.4    Poll-The, B.T.5    Van Der Knaap, M.S.6
  • 12
    • 79955821436 scopus 로고    scopus 로고
    • Expanding the clinical spectrum of 3-phosphoglycerate dehydrogenase deficiency
    • Tabatabaie L., Klomp L. W., Rubio-Gozalbo M. E., et al. Expanding the clinical spectrum of 3-phosphoglycerate dehydrogenase deficiency. J Inherit Metab Dis: 2011; 34 1 181 184
    • (2011) J Inherit Metab Dis , vol.34 , Issue.1 , pp. 181-184
    • Tabatabaie, L.1    Klomp, L.W.2    Rubio-Gozalbo, M.E.3
  • 13
    • 84863787887 scopus 로고    scopus 로고
    • A serine synthesis defect presenting with a Charcot-Marie-Tooth-like polyneuropathy
    • Méneret A., Wiame E., Marelli C., Lenglet T., Van Schaftingen E., Sedel F. A serine synthesis defect presenting with a Charcot-Marie-Tooth-like polyneuropathy. Arch Neurol: 2012; 69 7 908 911
    • (2012) Arch Neurol , vol.69 , Issue.7 , pp. 908-911
    • Méneret, A.1    Wiame, E.2    Marelli, C.3    Lenglet, T.4    Van Schaftingen, E.5    Sedel, F.6
  • 14
    • 66749157449 scopus 로고    scopus 로고
    • Novel mutations in 3-phosphoglycerate dehydrogenase (PHGDH) are distributed throughout the protein and result in altered enzyme kinetics
    • Tabatabaie L., de Koning T. J., Geboers A. JJM, van den Berg I. ET, Berger R., Klomp L. WJ. Novel mutations in 3-phosphoglycerate dehydrogenase (PHGDH) are distributed throughout the protein and result in altered enzyme kinetics. Hum Mutat: 2009; 30 5 749 756
    • (2009) Hum Mutat , vol.30 , Issue.5 , pp. 749-756
    • Tabatabaie, L.1    De Koning, T.J.2    Geboers, A.J.3    Van Den Berg, I.E.4    Berger, R.5    Klomp, L.W.6
  • 15
    • 10944270723 scopus 로고    scopus 로고
    • Prenatal and early postnatal treatment in 3-phosphoglycerate- dehydrogenase deficiency
    • DOI 10.1016/S0140-6736(04)17596-X, PII S014067360417596X
    • de Koning T. J., Klomp L. WJ, van Oppen A. C., et al. Prenatal and early postnatal treatment in 3-phosphoglycerate-dehydrogenase deficiency. Lancet: 2004; 364 9452 2221 2222 (Pubitemid 40018453)
    • (2004) Lancet , vol.364 , Issue.9452 , pp. 2221-2222
    • Koning, T.J.D.1    Klomp, L.W.J.2    Oppen, A.C.C.V.3    Beemer, P.F.A.4    Dorland, L.5    Berg, I.E.T.V.D.6    Berger, P.R.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.